All recorded activity
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $89M
2 disclosed · full round size, not this investor’s share
Rounds
2 in all activityBreezeBioDevelops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues
Role not disclosedGaluxDevelops AI-driven protein design platform for de novo antibody and drug discovery
Role not disclosed